Erratum to: Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index

Adv Ther. 2017 Jul;34(7):1773-1774. doi: 10.1007/s12325-017-0539-2.

Authors

Affiliations

¹ Department of Gastroenterology, Mitsui 20 Memorial Hospital, Tokyo, Japan. [email protected].
² Department of Gastroenterology, Mitsui 20 Memorial Hospital, Tokyo, Japan.
³ Department of Surgery, Shioda Hospital, Katsuura City, Japan.

No abstract available

Publication types

Published Erratum